Cingulate Therapeutics' Unattributed Round

Cingulate Therapeutics raised a round of funding on November 27, 2013.

Cingulate Therapeutics (CTx) is a privately-held biopharmaceutical company focused on the development of products for the treatment of Central Nervous System and Neurobiological Disorders. The company…

Articles about Cingulate Therapeutics' Unattributed Round: